Lilly (Eli) Balance Sheet
LLY / Health Care|15 years of annual SEC 10-K data (FY2011-FY2025)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 15 fiscal years. All figures from audited SEC 10-K filings.
Lilly (Eli) had $112.5B in total assets and $26.5B in shareholders' equity as of FY2025. Total debt was $40.9B against $7.3B in cash, resulting in $33.6B net debt.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score 1.02 (distress zone, below 1.8 threshold)
- Strong profit margin: 31.0%
- Low earnings quality (accrual-heavy earnings)
- Strong return on equity: 77.4%
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $7.3B | $3.3B | $2.8B | $2.1B | $3.8B | $3.7B | $2.3B | $7.3B | $3.7B | $4.6B | $3.7B | $3.9B | $3.8B | $6.0B | $4.5B |
| Accounts Receivable | $17.8B | $11.0B | $9.1B | $6.9B | $6.7B | $5.9B | $4.5B | $4.6B | $4.5B | $4.0B | $3.5B | $3.2B | $3.4B | $3.3B | $3.6B |
| Inventory | $13.7B | $7.6B | $5.8B | $4.3B | $3.9B | $4.0B | $3.2B | $3.1B | $4.5B | $3.6B | $3.4B | $2.7B | $2.9B | $2.6B | $2.3B |
| Current Assets | $55.6B | $32.7B | $25.7B | $18.0B | $18.5B | $17.5B | $13.7B | $20.5B | $19.2B | $15.1B | $12.6B | $11.9B | $13.1B | $13.0B | $14.2B |
| PP&E (Net) | $24.7B | $17.1B | $12.9B | $10.1B | $9.0B | $8.7B | $7.9B | $8.0B | $8.8B | $8.3B | $8.1B | $8.0B | $8.0B | $7.8B | $7.8B |
| Goodwill | $5.9B | $5.8B | $4.9B | $4.1B | $3.9B | $3.8B | $3.7B | $1.4B | $4.4B | $4.0B | $4.0B | $1.8B | $1.5B | $1.5B | $1.4B |
| Total Assets | $112.5B | $78.7B | $64.0B | $49.5B | $48.8B | $46.6B | $39.3B | $43.9B | $45.0B | $38.8B | $35.6B | $36.3B | $35.2B | $34.4B | $33.7B |
| Current Liabilities | $35.2B | $28.4B | $27.3B | $17.1B | $15.1B | $12.5B | $11.8B | $11.9B | $14.5B | $11.0B | $8.2B | $9.7B | $8.9B | $8.4B | $8.9B |
| Total Debt | $40.9B | $29.5B | $19.1B | $14.8B | $16.7B | $16.3B | $13.6B | $9.2B | $9.9B | $9.0B | $8.0B | $5.3B | $5.2B | $5.5B | $7.0B |
| Shareholders' Equity | $26.5B | $14.3B | $10.8B | $10.6B | $9.0B | $5.6B | $2.6B | $9.8B | $11.6B | $14.0B | $14.6B | $15.4B | $17.6B | $14.8B | $13.5B |